Medifast Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.53	89.3	90.93	94.44	87.69	104.18
Short-Term Investments	97.42	77.97	71.42	55.6	-	5.36
Cash & Short-Term Investments	168.95	167.27	162.34	150.04	87.69	109.54
Cash Growth	2.65%	3.04%	8.20%	71.10%	-19.95%	-37.21%
Inventory	21.4	20.23	42.42	54.59	118.86	180.04
Other Current Assets	12.28	14.18	9.64	19.4	16.24	17.28
Total Current Assets	202.63	201.68	214.4	224.03	222.78	306.87
Net Property, Plant & Equipment	42.56	38.46	48.68	67.11	75.65	80.59
Other Long-Term Assets	6.85	7.83	21.13	18.77	17.78	10.87
Total Assets	252.05	247.97	284.21	309.91	316.21	398.33
Accounts Payable	38.26	38.36	56.49	86.42	134.69	163.31
Current Portion of Leases	3.92	4.6	6.18	5.89	5.78	6.52
Other Current Liabilities	-	-	1.49	-	0.43	-
Total Current Liabilities	42.18	42.96	64.16	92.3	140.89	169.83
Long-Term Leases	12.18	6.09	9.94	16.13	20.28	26.02
Total Long-Term Liabilities	12.18	6.09	9.94	16.13	20.28	26.02
Total Liabilities	54.37	49.05	74.1	108.43	161.17	195.85
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Treasury Stock	-	-	-	-	-6.4	-
Additional Paid-in Capital	41.49	40.41	33.14	26.57	21.56	12.02
Accumulated Other Comprehensive Income	0.03	0.23	0.18	0.25	0.02	0.11
Retained Earnings	156.15	158.27	176.78	174.65	139.85	190.33
Shareholders' Equity	197.68	198.92	210.11	201.48	155.04	202.47
Total Liabilities & Equity	252.05	247.97	284.21	309.91	316.21	398.33
Total Debt	16.1	10.69	16.13	22.01	26.05	32.54
Net Cash (Debt)	152.85	156.58	146.22	128.03	61.64	77
Net Cash Growth	-2.38%	7.08%	14.21%	107.70%	-19.95%	-52.85%
Net Cash Per Share	13.88	14.26	13.34	11.72	5.47	6.52
Book Value	197.68	198.92	210.11	201.48	155.04	202.47
Book Value Per Share	17.95	18.11	19.17	18.45	13.75	17.14
Tangible Book Value	197.68	198.92	210.11	201.48	155.04	202.47
Tangible Book Value Per Share	17.95	18.11	19.17	18.45	13.75	17.14

SEC Filings: 10-K · 10-Q